Clinical Trials Directory

Trials / Completed

CompletedNCT06166979

Colonisation of Scalp by Topical Probiotic Micrococcus Luteus Q24

Assessment of Colonization and Scalp Quality Parameter Improvement by Topical Application of Probiotic Micrococcus Luteus Q24 in Healthy Adults.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
BLIS Technologies Limited · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the skin quality improvement and colonization efficacy following the application of probiotic Micrococcus luteus Q24 (BLIS Q24) to the scalp from a serum format in healthy adults.

Detailed description

This is a randomized double-blind baseline controlled pilot study with no crossover for the assessment of any changes to the microbial make-up of the skin (The local skin microbiome), detection of colonization by the probiotic bacterium (BLIS Q24) on the skin on the scalp and to evaluate the changes in skin quality parameters following topical application of probiotic in a serum format.

Conditions

Interventions

TypeNameDescription
OTHERActive Comparator: Study Group A: Blis Q24 Serum at higher doseActive Comparator: Study Group A: Blis Q24 Serum at 1e8 cfu/ dose (Active)
OTHERActive Comparator: Study Group B: Blis Q24 Serum at lower doseActive Comparator: Study Group A: Blis Q24 Serum at 1e6 cfu/ dose (Active)

Timeline

Start date
2024-01-15
Primary completion
2024-02-25
Completion
2024-07-31
First posted
2023-12-12
Last updated
2025-05-18

Locations

1 site across 1 country: New Zealand

Source: ClinicalTrials.gov record NCT06166979. Inclusion in this directory is not an endorsement.